USA –The FDA announced that it has approved Eli Lilly’s injected drug tirzepatide, marketed under the brand name Mounjaro, to help improve blood sugar control in adults with type 2…
Read MoreLilly’s blockbuster diabetes drug wins FDA approval
Tag: Diabetes
GOQii launches lifestyle medicine program for diabetes management
INDIA –GOQii has launched a diabetes-specific integrated lifestyle medicine program called GOQii Diabetes Care to assist people with diabetes in managing their condition and taking ownership of their health through…
Read MoreManipalCigna Health Insurance launches comprehensive healthcare plan for better coverage and care
INDIA –ManipalCigna Health Insurance has launched the ProHealth Prime’ plan that covers all types of hospitalization expenses, enhancing healthcare coverage and care. This comprehensive cover plan comes with revolutionary features…
Read MoreApollo Hospitals introduces new foot reconstruction treatment for diabetic patients
INDIA –Apollo Hospitals has opened a unique multidisciplinary Centre of Excellence for Diabetic Foot Management (CoEDFM) for diabetic patients who are known to be prone to foot-related ailments at its…
Read MoreKenyan e-pharmacy MYDAWA partners Novo Nordisk to promote insulin therapy
KENYA – The leading online pharmacy in Kenya MYDAWA has partnered with multinational pharmaceutical giant Novo Nordisk to boost access to affordable insulin for diabetes treatment. Founded in 1923, Novo…
Read MoreGlenmark launches fixed-dose combination for diabetic patients
INDIA – Glenmark Pharmaceuticals has announced the launch of a novel fixed-dose combination (FDC) of Teneligliptin and Pioglitazone for adults with uncontrolled Type 2 diabetes in India. India is known…
Read MoreWHO warns about rising burden of noncommunicable diseases in Africa
AFRICA – New data released by the World Health Organization (WHO) reveals that Noncommunicable diseases (NCDs) are increasingly becoming the main cause of mortality in sub-Saharan Africa, where the diseases…
Read MoreEli Lilly and Boehringer Ingelheim’s Jardiance score EU approval for treating heart failure
EUROPE – Eli Lilly and Boehringer Ingelheim (BI) have received another significant approval, this time from the European Union (EU), for their sodium-glucose co-transporter-2-inhibitor (SGLT2-I), Jardiance (empagliflozin). Eli Lilly and…
Read MoreDexcom’s next-gen G7 diabetes sensor secures European approval
EUROPE – Dexcom has received European approval for the G7 continuous glucose monitor, the latest generation of its wearable diabetes sensor, for adults and children aged two and up. The…
Read MoreMedtronic India launches MiniMed 780G for diabetes management
INDIA –Medtronic, a global leader in healthcare technology has announced the launch of MiniMed 780G system in India. MiniMed 780G, a next-generation closed-loop insulin pump system for the treatment of…
Read More